Citations

Showing 10 of 108152 citations.

Response by Fitzgerald and Brinjikji to Letter Regarding Article, “Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source”
Brinjikji, Waleed , Fitzgerald, Seán

Mayo Clinic

Stroke | September 13, 2019 | Volume: 50 | Issue: 10 | Pages: No page available

10.1161/strokeaha.119.026856 | PMID 31514702 Get It

Activated Clotting Time and Radial Artery Occlusion
Gulati, Rajiv , Mamas, Mamas A. , Mamas, Mamas

Mayo Clinic

Circulation: Cardiovascular Interventions | September 13, 2019 | Volume: 12 | Issue: 9 | Pages: No page available

10.1161/circinterventions.119.008398 | PMID 31514522 Get It

Effective Use of Percutaneous Stellate Ganglion Blockade in Patients With Electrical Storm
Tian, Ying , Wittwer, Erica D. , Xiao, Peilin , Mulpuru, Siva K. , Deshmukh, Abhishek , Lee, Hon-Chi, Ackerman, Michael J. , Asirvatham, Samuel J. , Munger, Thomas M. , Liu, Xing-Peng , Friedman, Paul A. , Cha, Yong‐Mei , Asirvatham, Samuel J , Kapa, Suraj , McLeod, Christopher J. , Noseworthy, Peter A.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 13, 2019 | Volume: 12 | Issue: 9 | Pages: No page available

10.1161/circep.118.007118 | PMID 31514529 Get It

Background: Percutaneous stellate ganglion blockade (SGB) has been used for drug-refractory electrical storm due to ventricular arrhythmia (VA); however, the effects and long-term outcomes have not been well studied. Methods: This study included 30 consecutive patients who had drug-refractory electrical storm and underwent percutaneous SGB between October 1, 2013, and March 31, 2018. Bupivacaine, alone or combined with lidocaine, was injected into the neck with good local anesthetic spread in the vicinity of the left stellate ganglion (n=15) or both stellate ganglia (n=15). Data were collected for patient clinical characteristics, immediate and long-term outcomes, and procedure-related complications. Results: Clinical characteristics included age, 58±14 years; men, 73.3%; and left ventricular ejection fraction, 34±16%. At 24 hours, 60% of patients were free of VA. Patients whose VA was controlled had a lower hospital mortality rate than patients whose VA continued (5.6% versus 50.0%; P =0.009). Implantable cardioverter-defibrillator interrogation showed a significant 92% reduction in VA episodes from 26±41 to 2±4 in the 72 hours after SGB ( P <0.001). Patients who died during the same hospitalization (n=7) were more likely to have ischemic cardiomyopathy (100% versus 43.5%; P =0.03) and recurrent VA within 24 hours (85.7% versus 26.1%; P =0.009). There were no procedure-related major complications. Conclusions: SGB effectively attenuated electrical storm in more than half of patients without procedure-related complications. Percutaneous SGB may be considered for stabilizing ventricular rhythm in patients for whom other therapies have failed.
Spinal Cord Injury Results in Chronic Mechanical Stiffening
Cooper, John G. , Sicard, Delphine , Sharma, Sripadh , Gulden, Stephanie Van, McGuire, Tammy L., Pareja‐Cajiao, Miguel , Tschumperlin, Daniel J. , Cajiao, Miguel Pareja, Kessler, John A.

Mayo Clinic

Journal of Neurotrauma | September 13, 2019 | Volume: 37 | Issue: 3 | Pages: 494-506

10.1089/neu.2019.6540 | PMID 31516087 Get It

Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is thought to present both molecular and mechanical barriers to neuronal regeneration. The scar consists of a meshwork of reactive glia and deposited, cross-linked, extracellular matrix (ECM) that has long been assumed to present a mechanically “stiff” blockade. However, remarkably little quantitative information is available about the rheological properties of chronically injured spinal tissue. In this study we utilize atomic force microscopy microindentation to provide quantitative evidence of chronic mechanical stiffening after SCI. Using the results of this tissue characterization, we assessed the sensitivity of both mouse and human astrocytes in vitro and determined that they are exquisitely mechanosensitive within the relevant range of substrate stiffness observed in the injured/uninjured spinal cord. We then utilized a novel immune modifying nanoparticle (IMP) treatment as a tool to reveal fibrotic scarring as one of the key drivers of mechanical stiffening after SCI in vivo . We also demonstrate that glial scar-forming astrocytes form a highly aligned, anisotropic network of glial fibers after SCI, and that IMP treatment mitigates this pathological alignment. Taken together, our results identify chronic mechanical stiffening as a critically important aspect of the complex lesion milieu after SCI that must be considered when assessing and developing potential clinical interventions for SCI.
Diagnosis of hypothenar hammer syndrome in a patient with acute ulnar artery occlusion
St‐Pierre, Frédérique , Shepherd, Roger F.J., Bartlett, Matthew , Shepherd, Roger F, Bartlett, Matthew A

Mayo Clinic

BMJ Case Reports | September 13, 2019 | Volume: 12 | Issue: 9 | Pages: e230963

10.1136/bcr-2019-230963 | PMID 31519720 Get It

A 56-year-old truck driver with a history of tobacco use presented with acute onset digital ischaemia in the ulnar distribution of his dominant hand, associated with severe pain. Occupational exposures included extensive manual labour and prolonged vibratory stimuli. Workup with Doppler and angiography confirmed the diagnosis of hypothenar hammer syndrome (HHS). After the failure of medical management, he underwent ulnar artery thrombectomy with reconstruction and arterial bypass grafting. His pain improved significantly postsurgically, and he was able to return to a normal routine. This case illustrates the classic presentation, examination, imaging findings and management options of HHS. HHS should be considered in patients with digital ischaemia and associated occupational exposures. Diagnosing the condition appropriately allows for optimal management, aiming at minimising symptoms and maximising quality of life.
Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug
Mishra, Tushar , Shokr, Mohamed , Ahmed, Abdelrahman , Afonso, Luis

Mayo Clinic

BMJ Case Reports | September 13, 2019 | Volume: 12 | Issue: 9 | Pages: e230499

10.1136/bcr-2019-230499 | PMID 31519717 Get It

5-Fluorouracil (5-FU) is the third most common chemotherapeutic agent for treating solid cancers and the second most common to cause cardiotoxicity. We present a rare case of acute reversible severe left ventricular systolic dysfunction associated with 5-FU. A 54-year-old woman with a history of stage IV gastric cancer presented with features of transient ischaemic attack after receiving the first dose of FLOT (5-FU, leucovorin, oxaliplatin and docetaxel). During the diagnostic workup, it was found that her ejection fraction was severely reduced to 15% with features of global hypokinesis, which later improved back to 65% within 13 days. These cases challenge our current understanding of the underlying mechanisms of this cardiotoxicity. Additionally, even though the patient did not experience any cardiac symptoms, it is important to monitor these patients closely as they are at high risk for fatal complications like arrhythmia and thrombus formation.
Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites
Hobson, Nicholas , Polster, Sean P. , Flemming, Kelly D. , Shu, Yunhong , Huston, John , Gerrard, Chandra Y., Selwyn, Reed , Mabray, Marc C. , Zafar, Atif , Girard, Romuald , Carrión‐Penagos, Julián , Chen, Yu Fen, Parrish, Todd B. , Zhou, Xiaohong Joe , Stadnik, Agnieszka , Koskimäki, Janne , Turley, Dallas, Awad, Issam A. , Flemming, Kelly, Girard, Romuald , Carrión-Penagos, Julián , Zhou, Xiaohong Joe , Mabray, Marc C , Flemming, Kelly D , Hobson, Nicholas , Polster, Sean P , Cao, Ying , Koenig, James I. , Shenkar, Robert , Dimov, Alexey , Carroll, Timothy

Mayo Clinic

Journal of Magnetic Resonance Imaging | September 13, 2019 | Volume: 51 | Issue: 4 | Pages: 1192-1199

10.1002/jmri.26927 | PMID 31515878 Get It

BackgroundQuantitative susceptibility mapping (QSM) and dynamic contrast‐enhanced quantitative permeability (DCEQP) on magnetic resonance (MR) have been shown to correlate with neurovascular disease progression as markers of vascular leakage and hemosiderin deposition. Applying these techniques as monitoring biomarkers in clinical trials will be necessary; however, their validation across multiple MR platforms and institutions has not been rigorously verified.PurposeTo validate quantitative measurement of MR biomarkers on multiple instruments at different institutions.Study TypePhantom validation between platforms and institutions.Phantom ModelT1/susceptibility phantom, two‐compartment dynamic flow phantom.Field Strength/Sequence3T/QSM, T1 mapping, dynamic 2D SPGR.AssessmentPhilips Ingenia, Siemens Prisma, and Siemens Skyra at three different institutions were assessed. A QSM phantom with concentrations of gadolinium, corresponding to magnetic susceptibilities of 0, 0.1, 0.2, 0.4, and 0.8 ppm was assayed. DCEQP was assessed by measuring a MultiHance bolus as the consistency of the width ratio of the curves at the input and outputs over a range of flow ratios between outputs.Statistical TestsEach biomarker was assessed by measures of accuracy (Pearson correlation), precision (paired t‐test between repeated measurements), and reproducibility (analysis of covariance [ANCOVA] between instruments).ResultsQSM accuracy of r2 > 0.997 on all three platforms was measured. Precision (P = 0.66 Achieva, P = 0.76 Prisma, P = 0.69 Skyra) and reproducibility (P = 0.89) were good. T1 mapping of accuracy was r2 > 0.98. No significant difference between width ratio regression slopes at site 2 (P = 0.669) or site 3 (P = 0.305), and no significant difference between width ratio regression slopes between sites was detected by ANCOVA (P = 0.48).Data ConclusionThe phantom performed as expected and determined that MR measures of QSM and DCEQP are accurate and consistent across repeated measurements and between platforms.Level of Evidence: 1Technical Efficacy Stage: 2J. Magn. Reson. Imaging 2020;51:1192–1199.
A Machine Learning-Based Triage Tool for Children With Acute Infection in a Low Resource Setting*
Kwizera, Arthur , Kissoon, Niranjan , Musa, Ndidiamaka, Urayeneza, Olivier, Mujyarugamba, Pierre , Harmon, Lori, Farmer, Joseph C. , Dünser, Martin W. , Meier, Jens , Patterson, Andrew J.

Mayo Clinic

Pediatric Critical Care Medicine | September 13, 2019 | Volume: 20 | Issue: 12 | Pages: e524-e530

10.1097/pcc.0000000000002121 | PMID 31805020 Get It

Objectives: To deploy machine learning tools (random forests) to develop a model that reliably predicts hospital mortality in children with acute infections residing in low- and middle-income countries, using age and other variables collected at hospital admission. Design: Post hoc analysis of a single-center, prospective, before-and-after feasibility trial. Setting: Rural district hospital in Rwanda, a low-income country in Sub-Sahara Africa. Patients: Infants and children greater than 28 days and less than 18 years of life hospitalized because of an acute infection. Interventions: None. Measurements and Main Results: Age, vital signs (heart rate, respiratory rate, and temperature) capillary refill time, altered mental state collected at hospital admission, as well as survival status at hospital discharge were extracted from the trial database. This information was collected for 1,579 adult and pediatric patients admitted to a regional referral hospital with an acute infection in rural Rwanda. Nine-hundred forty-nine children were included in this analysis. We predicted survival in study subjects using random forests, a machine learning algorithm. Five prediction models, all including age plus two to five other variables, were tested. Three distinct optimization criteria of the algorithm were then compared. The in-hospital mortality was 1.5% (n = 14). All five models could predict in-hospital mortality with an area under the receiver operating characteristic curve ranging between 0.69 and 0.8. The model including age, respiratory rate, capillary refill time, altered mental state exhibited the highest predictive value area under the receiver operating characteristic curve 0.8 (95% CI, 0.78–0.8) with the lowest possible number of variables. Conclusions: A machine learning-based algorithm could reliably predict hospital mortality in a Sub-Sahara African population of 949 children with an acute infection using easily collected information at admission which includes age, respiratory rate, capillary refill time, and altered mental state. Future studies need to evaluate and strengthen this algorithm in larger pediatric populations, both in high- and low-/middle-income countries.
Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
Vranić, Semir , Senarathne, Wijendra, Poorman, Kelsey , Pockaj, Barbara A. , Gatalica, Zoran , Stafford, Phillip

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | September 13, 2019 | Volume: 28 | Issue: 9 | Pages: 661-668

10.1097/pai.0000000000000808 | PMID 31517642 Get It

The breast is a rare site for metastases, and their molecular characteristics have not been studied yet. Intrinsic molecular genetics, cancer characteristics, and breast tissue immune responses in diverse metastases to the breast have not been previously studied. We identified 64 patients with cancers metastatic to the breast: 51 carcinomas and 13 melanomas. Programmed death ligand 1 (PD-L1), steroid receptors, and HER2/neu expressions were evaluated using immunohistochemistry. Gene sequencing, copy number alterations, microsatellite instability, and tumor mutational burden were performed using next-generation sequencing platforms. The 3 most common primary sites for metastatic carcinomas were lung (37%), ovary (29%), and fallopian tubes/peritoneum (14%). TP53 mutations were commonly (50%) observed among the carcinoma cases, while other mutations were characteristic for the primary cancers (VHL in renal, BRCA1 in the fallopian tube, and BRAF in melanomas). High tumor mutational burden was detected in 5/14 carcinomas and 3/7 melanomas. Tumor cell PD-L1 expression was detected in 6 carcinomas, but not in any of the melanomas, whereas immune cells’ expression of PD-L1 was seen in 17 carcinomas and 6 melanomas. Estrogen receptor status was positive in 13/49 carcinomas including 12 adenocarcinomas originating from the ovary and fallopian tube or peritoneum and 1 duodenal neuroendocrine carcinoma. No carcinoma was HER2/neu positive. Intrinsic genetic characteristics of the metastases to the breast followed the pattern commonly seen in primary tumors. Biomarkers of potential benefit to immune checkpoint inhibition therapy were limited to PD-L1-positive non–small cell lung cancer. No common characteristics of the heterogeneous group of tumor metastases to this organ were identified.